(Q39431252)

11 September 2017

title

A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine (English)

1 reference

11 September 2017

1 reference

Gallagher RM

1

1 reference

11 September 2017

Dennish G

series ordinal

2

1 reference

11 September 2017

Spierings EL

series ordinal

3

1 reference

11 September 2017

Chitra R

series ordinal

4

1 reference

11 September 2017

language of work or name

1 reference

1 February 2000

1 reference

11 September 2017

1 reference

11 September 2017

volume

40

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

119-128

1 reference

An update on the epidemiology of migraine

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Migraine symptoms: results of a survey of self-reported migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Increasing the options for effective migraine management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00017.X

10.1046/J.1526-4610.2000.00017.X

21 January 2018

Identifiers

DOI

1 reference

release_o27ffuuc7vdvnceyjk7zshw5u4

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o27ffuuc7vdvnceyjk7zshw5u4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference